Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24978421 | 0.97 | CDK2 (0.42) | HSD17B10KDM4EKMT2ATSHRALDH1A1 | |
| SCHEMBL23330649 | 0.83 | HDAC3 (0.41) | KMT2ATSHRALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL23331001 | 0.82 | ALDH1A1 (0.39) | KDM4EKMT2ATSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL24978410 | 0.82 | CETP (0.40) | HSD17B10KDM4EKMT2ATSHRALDH1A1 | |
| SCHEMBL23300898 | 0.82 | ACVRL1 (0.38) | KMT2AALDH1A1HPGDSMN1; SMN2NPC1 | |
| SCHEMBL23331072 | 0.82 | HDAC1 (0.41) | HSD17B10KDM4EKMT2A | |
| SCHEMBL24978675 | 0.80 | NAMPT (0.38) | POLBMAPK10 | |
| SCHEMBL23330489 | 0.76 | MAPT (0.44) | HSD17B10KDM4ETSHRALDH1A1HPGD | |
| SCHEMBL23331246 | 0.74 | P2RX7 (0.38) | KDM4EKMT2AALDH1A1SMN1; SMN2POLB | |
| SCHEMBL23331262 | 0.74 | TP53 (0.40) | HSD17B10KDM4EKMT2AALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230028221-A1 | EED INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | JING MEDICINE TECHNOLOGY (SHANGHAI) LTD. (CN) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230028221-A1 | EED INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | CYP4F11, CYP4A11, HSD11B1 | HSD17B10 332/4885KDM4E 2018/4885KMT2A 3987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.